Skip to search formSkip to main contentSkip to account menu

ethynyluracil/fluorouracil

Known as: 776C85/5-FU, Eniluracil/Fluorouracil, GW776/5-Fluorouracil 
A combination tablet of ethynyluracil and fluorouracil. Fluorouracil is an antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with… 
National Institutes of Health

Related topics

Related topics

8 relations

Broader (1)

Chemotherapy Regimen
DNADNA Synthesis InhibitionDihydropyrimidine dehydrogenaseFluorouracil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer.
BACKGROUND Eniluracil is an effective inactivator of dihydropyrimidine dehydrogenase, the initial and rate limiting enzyme in the… 
2000
2000
Clinical Development of Eniluracil/Fluorouracil: an Oral Treatment for Patients with Solid Tumors
Eniluracil (776C85, GW776) inactivatesdihydropyrimidine dehydrogenase (DPD), the principal enzyme of5-fluorouracil (5-FU… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)